tiprankstipranks
Trending News
More News >
Delta-Fly Pharma, Inc. (JP:4598)
:4598
Japanese Market

Delta-Fly Pharma, Inc. (4598) Drug Pipeline

Compare
0 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Venetoclax, Dfp-10917
Leukemia, Myeloid, Acute
Phase I/II
Recruiting
DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
Apr 19, 2024
Dfp-14927
Cancer, Solid Tumor
Phase I
Recruiting
Trial of DFP-14927 in Advanced Solid Tumors
Apr 25, 2019
Fludarabine, Azacitidine, Cytarabine, Decitabine, Venetoclax, Etoposide, Idarubicin, Mitoxantrone, Dfp-10917, Cladribine
Leukemia, Myeloid, Acute
Phase III
Recruiting
Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage
Apr 11, 2019

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Delta-Fly Pharma, Inc. (4598) have in its pipeline
      4598 is currently developing the following drugs: Venetoclax, Dfp-10917, Dfp-14927, Fludarabine, Azacitidine, Cytarabine, Decitabine, Venetoclax, Etoposide, Idarubicin, Mitoxantrone, Dfp-10917, Cladribine. These drug candidates are in various stages of clinical development as the company works toward FDA approval.